NCT06073756Not yet recruiting
Neutrophil-lymphocyte and Platelet-lymphocyte Ratios and Their Relations to Vascular Comlications and Glycemic Control in Patients With Type 2 Diabetes Attending The Diabetes Center of Assiut University Hospitals
Source: ClinicalTrials.gov · Last updated 10 Oct 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Evaluate PLR and NLR and their assiotation to vascular complications and glycemic control in type 2 DM
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 106 (estimated)
- First submitted
- 3 Oct 2023
- Start date
- Dec 2023
- Primary completion date
- Oct 2027
- Lead sponsor
- Assiut University
- Diseases
- Type 2 diabetes
- NCT number
- NCT06073756
What you commit to
- Study type: Observational
- Planned participants: 106
- From Dec 2023 to the primary completion date, Oct 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Lab values
- Patients with, type 1 diabetes mellitus
- Idiopathic thrombocytopenic purpura,
- liver cell failure
- Myeloproliferative neoplasm
- patients on anticoagulant drugs , anti platelet drugs or on steroids were excluded from the study
Who the study is looking for
- Type 2 diabetes mellitus (T2DM) patients with good glycemic control and have HBA1C \<7and ages ranging from ≥18 old. And poor glycemic control and have HBA1C ≥7 and ages rang from ≥ 18 years old
Age in the registry: 18 years to 75 years · Sex: All
This page is information, not medical advice. Discuss any trial with your doctor.